NextPlat Q1 FY26 net loss narrows to $1.13 million; revenue falls 29% to $9.86 million

NextPlat Corp

NextPlat Corp

NXPL

0.00
  • NextPlat posted a net loss of USD 1.13 million, narrowing from USD 1.94 million a year earlier; loss attributable to common stockholders narrowed to USD 1.12 million, or USD 0.42 per share.
  • Revenue fell 29% to USD 9.86 million versus year-ago quarter, as pharmacy prescription revenue, net dropped 50% to USD 4.78 million.
  • Pharmacy contract revenue rose 31% to USD 1.87 million, while e-Commerce revenue increased 6% to USD 3.2 million.
  • Operating cash outflow widened to USD 2.58 million from USD 2.06 million, leaving cash at USD 11.01 million at quarter-end.
  • Management cited lower reimbursement rates and reduced prescription volume as drivers of the pharmacy prescription revenue decline, while pointing to new contracted medication fulfillment services for the contract revenue increase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextPlat Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-017156), on May 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.